Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury
Brief Summary
The purpose of this study is to identify the optimal dosing strategy for low-dose ketamine infusions in adult acute burn injury patients when used with usual pain medications.
Study Design
Study type: | Interventional |
---|---|
Status: | Withdrawn |
Study results: | No Results Available |
Age: | 18 Years and older (Adult, Older Adult) |
Enrollment: | 0 () |
Funded by: | Other |
Masking |
Clinical Trial Dates
Start date: | Apr 01, 2017 | |
---|---|---|
Primary Completion: | May 24, 2018 | |
Completion Date: | May 24, 2018 | |
Study First Posted: | Mar 29, 2017 | |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Oct 31, 2018 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
This Aim will identify the safest and most optimal dosing strategy for low-dose ketamine infusions. While the hourly rate for low-dose ketamine infusions used for adjunctive analgesia appears to be well-established both in the medical literature and our institutional protocols, there is no information available for this specific population of patients (adult acute burn injury) to know whether the infusions should be utilized for discrete periods of time or should be given continuously. Findings from this study will help provide preliminary data on the optimal dosing strategy of this medication for adjunctive analgesia in this population.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 18 |
More Details
NCT Number: | NCT03095222 |
---|---|
Other IDs: | STUDY00004424 |
Study URL: | https://ClinicalTrials.gov/show/NCT03095222 |
Last updated: Jun 17, 2022